Clinical remission in patients with severe eosinophilic asthma treated with benralizumab who were randomised to reduce their inhaled corticosteroid/formoterol dose: SHAMAL post-hoc analysis

被引：0
|
作者：
Devouassoux, Gilles [1 ,2 ,3 ]
Jackson, David J. [4 ]
Kaessner, Frank F. [5 ]
Caruso, Cristiano [6 ]
Shavit, Anat [7 ]
Olinger, Lynda [8 ,9 ]
Menzies-Gow, Andrew [7 ]
机构：
[1] Hop Croix Rousse, Serv Pneumol, Lyon, France
[2] Univ Claude Bernard Lyon 1, VIRPATH, Villeurbanne, France
[3] CRISALIS, F CRIN INSERM Network, Pavillon Ler, Toulouse, France
[4] Kings Coll London, Guys Hosp, Sch Immunol & Microbial Sci, London, England
[5] MECS GmbH, Ambulantes Zentrum Lungenkrankheiten & Schlafmed, Cottbus, Brandenburg, Germany
[6] Fdn Policlin Univ Agostino Gemelli IRCCS, UOSD DH Internal Med & Digest Dis, Rome, Italy
[7] AstraZeneca, BioPharmaceut Med Resp & Immunol, Cambridge, England
[8] Cytel Inc, Waltham, MA USA
[9] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Cambridge, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA1194
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 46 条
  • [21] Towards clinical remission in severe asthma: An analysis of patients treated with benralizumab in the phase 3b ANDHI trial
    Harrison, Tim W.
    Louis, Renaud
    Carstens, Donna
    Cohen, David
    Katial, Rohit
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 565 - 565
  • [22] Towards clinical remission in severe asthma: An analysis of patients treated with benralizumab in the phase 3b ANDHI trial
    Harrison, Tim W.
    Louis, Renaud
    Kwiatek, Justin
    Papeleu, Peggy
    Cohen, David
    Keeling, Nanna
    Katial, Rohit
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (19-20) : 737 - 737
  • [23] Is Asthma Clinical Remission Achievable by Inhaled Therapy? A Post-Hoc Analysis of Single Inhaler Triple Therapy with FF/UMEC/VI in the CAPTAIN Trial
    Lugogo, Njira
    Oppenheimer, John
    Crawford, Jodie
    Corbridge, Tom
    Howarth, Peter
    Igboekwe, Emmeline
    Moore, Alison
    Noorduyn, Stephen
    Slade, David
    Weng, Stephen
    Pavord, Ian
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB266 - AB266
  • [24] Clinical remission by BMI in patients with severe eosinophilic asthma (SEA) over 1 year post benralizumab: real-world XALOC-2 programme
    Lommatzsch, Marek
    Rothe, Thomas
    Emmanuel, Benjamin
    Tran, Trung N.
    Menzies-Gow, Andrew
    Shavit, Anat
    Cohen, David
    Ho, Calvin N.
    Plate, Tanja
    Kayaniyil, Sheena
    Herreman, An
    Schuoler, Claudio
    Dupont, Lieven
    Penz, Erika
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [25] Clinical Remission Outcome in Patients with Severe Asthma with an Eosinophilic Phenotype (SA-EP) Receiving Mepolizumab: A Post-Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial
    Chen, Ruchong
    Dai, Yuanrong
    Yang, Danrong
    Liu, Chuntao
    Han, Wei
    Gu, Wei
    Cao, Jie
    Zhou, Qiong
    Howarth, Peter
    Weng, Stephen
    Xiong, Cui
    Huang, Jie
    Liang, Peiwen
    Zhong, Nanshan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB99 - AB99
  • [26] Approaching Clinical Remission in Severe Asthma: An Analysis of Patients With Comorbid Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Treated With Benralizumab Across Five Clinical Trials
    Louis, R. E.
    Harrison, T.
    Shavit, A.
    Kwiatek, J.
    Cohen, D.
    Keeling, N.
    Cosio, B. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [27] Rates of asthma attacks in patients with previously inadequately controlled mild asthma treated in clinical practice with combination drug therapy: An exploratory post-hoc analysis
    Dal Negro R.W.
    Borderias L.
    Zhang Q.
    Fan T.
    Sazonov V.
    Guilera M.
    Taylor S.D.
    BMC Pulmonary Medicine, 9 (1)
  • [28] Clinical remission in patients with severe eosinophilic asthma with benralizumab according to body mass index status in an integrated analysis of the real-world XALOC-1 study
    Jackson, D.
    Pelaia, G.
    Padilla-Galo, A.
    Tran, T. N.
    Shih, V.
    Cohen, D.
    Watt, M.
    Kayaniyil, S.
    Boarino, S.
    Nuevo, J.
    Kwiatek, J.
    Shavit, A.
    Emmanuel, B.
    Nair, P.
    ALLERGY, 2023, 78
  • [29] Clinical Burden of Chronic Rhinosinusitis with Nasal Polyps in Patients with Severe Eosinophilic Asthma: A Post Hoc Analysis of Data from MENSA and COSMOS
    Smith, S.
    Price, R. G.
    Mollo, M. R.
    Howarth, P.
    Yancey, S. W.
    Cavaliere, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [30] Low-Dose Budesonide Treatment Reduces Severe Asthma-Related Events In Patients With Infrequent Asthma Symptoms At Baseline: A Post-Hoc Analysis Of The Start Study
    Reddel, H. K.
    Busse, W. W.
    Pedersen, S.
    Tan, W. C.
    Chen, Y. -Z.
    Jorup, C.
    Lythgoe, D.
    O'Byrne, P. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
12345